Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations.
ALK
BRAF
EGFR
HER2
MET
RET
ROS1
anti-PD1/PD-L1 immunotherapy
non-small cell lung cancer
oncogenic driver
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Jun 2021
11 Jun 2021
Historique:
received:
06
05
2021
revised:
04
06
2021
accepted:
08
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
15
7
2021
Statut:
epublish
Résumé
Anti-PD1/PD-L1 immunotherapy has emerged as a standard of care for stage III-IV non-small cell lung cancer (NSCLC) over the past decade. Patient selection is usually based on PD-L1 expression by tumor cells and/or tumor mutational burden. However, mutations in oncogenic drivers such as
Identifiants
pubmed: 34208111
pii: ijms22126288
doi: 10.3390/ijms22126288
pmc: PMC8230861
pii:
doi:
Substances chimiques
B7-H1 Antigen
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Oncoimmunology. 2017 Jul 26;6(11):e1356145
pubmed: 29147605
N Engl J Med. 2009 Sep 3;361(10):947-57
pubmed: 19692680
J Thorac Oncol. 2018 Aug;13(8):1146-1155
pubmed: 29730379
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Front Immunol. 2020 Nov 25;11:527750
pubmed: 33324391
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
J Clin Oncol. 2013 Jun 1;31(16):1997-2003
pubmed: 23610105
Lung Cancer. 2018 Oct;124:117-124
pubmed: 30268448
Clin Lung Cancer. 2019 Nov;20(6):e593-e596
pubmed: 31395437
Lung Cancer. 2020 Feb;140:8-18
pubmed: 31838169
Cancer Discov. 2018 Jul;8(7):822-835
pubmed: 29773717
Clin Cancer Res. 2016 Sep 15;22(18):4585-93
pubmed: 27225694
J Manag Care Spec Pharm. 2020 Aug;26(8):981-986
pubmed: 32329651
Clin Lung Cancer. 2020 Jul 15;:
pubmed: 32807653
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Lancet Respir Med. 2019 May;7(5):387-401
pubmed: 30922878
Lancet Oncol. 2016 May;17(5):577-89
pubmed: 27083334
J Surg Res. 2018 Oct;230:181-185
pubmed: 30072189
J Thorac Oncol. 2020 Apr;15(4):628-636
pubmed: 31945494
J Thorac Oncol. 2014 Feb;9(2):154-62
pubmed: 24419411
Lancet Oncol. 2017 Nov;18(11):1454-1466
pubmed: 28958502
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Target Oncol. 2017 Oct;12(5):563-569
pubmed: 28624922
J Clin Oncol. 2017 Aug 10;35(23):2613-2618
pubmed: 28520527
N Engl J Med. 2020 Sep 3;383(10):931-943
pubmed: 32469185
Clin Lung Cancer. 2021 Jan 7;:
pubmed: 33582070
Ann Oncol. 2017 Feb 1;28(2):292-297
pubmed: 27803005
Lancet Oncol. 2016 Dec;17(12):1653-1660
pubmed: 27825636
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Ann Oncol. 2020 May;31(5):599-608
pubmed: 32178965
Ann Oncol. 2018 Oct 1;29(10):2085-2091
pubmed: 30165371
J Thorac Oncol. 2021 May;16(5):868-872
pubmed: 33539970
Semin Intervent Radiol. 2013 Jun;30(2):93-8
pubmed: 24436524
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Cancer Treat Rev. 2018 Dec;71:47-58
pubmed: 30359792
Lancet. 2016 Apr 2;387(10026):1415-1426
pubmed: 26777916
N Engl J Med. 2020 Oct 1;383(14):1328-1339
pubmed: 32997907
Lancet Oncol. 2018 Apr;19(4):521-536
pubmed: 29545095
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):632-641
pubmed: 27956436
Cancer Discov. 2021 Feb 25;:
pubmed: 33632775
Lung Cancer. 2013 Nov;82(2):179-89
pubmed: 24011633
Virchows Arch. 2020 Aug;477(2):207-217
pubmed: 31989260
Crit Rev Oncol Hematol. 2021 Jan;157:103194
pubmed: 33316418
Lancet Oncol. 2011 Aug;12(8):735-42
pubmed: 21783417
Lancet. 2017 Jan 21;389(10066):255-265
pubmed: 27979383
N Engl J Med. 2014 Dec 4;371(23):2167-77
pubmed: 25470694
Nat Rev Cancer. 2014 Aug;14(8):535-46
pubmed: 25056707
Lung Cancer. 2018 Apr;118:36-40
pubmed: 29572000
J Thorac Oncol. 2018 Aug;13(8):1138-1145
pubmed: 29874546
Oncoimmunology. 2020 Apr 12;9(1):1744898
pubmed: 33457089
J Thorac Oncol. 2017 May;12(5):878-883
pubmed: 28104537
J Clin Oncol. 2019 Mar 1;37(7):537-546
pubmed: 30620668
Anticancer Drugs. 2019 Jun;30(5):537-541
pubmed: 30762593
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Lancet. 2017 Mar 4;389(10072):917-929
pubmed: 28126333
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Clin Chest Med. 2011 Dec;32(4):605-44
pubmed: 22054876
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
Ann Oncol. 2014 Oct;25(10):1935-1940
pubmed: 25009014
Eur J Cancer. 2019 Mar;109:28-35
pubmed: 30685684
Lancet Oncol. 2013 Sep;14(10):953-61
pubmed: 23948351
N Engl J Med. 2018 Nov 22;379(21):2027-2039
pubmed: 30280657
Lung Cancer. 2018 Nov;125:86-92
pubmed: 30429043
JAMA Oncol. 2020 May 1;6(5):661-674
pubmed: 32271377
J Thorac Oncol. 2015 Jun;10(6):910-23
pubmed: 25658629
Br J Cancer. 2015 Jan 6;112(1):95-102
pubmed: 25349974
Lancet Oncol. 2017 Dec;18(12):1590-1599
pubmed: 29074098
N Engl J Med. 2020 Aug 27;383(9):813-824
pubmed: 32846060
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Cancer Med. 2019 Apr;8(4):1521-1529
pubmed: 30790471
Cancer Biol Med. 2018 Nov;15(4):434-442
pubmed: 30766753
Ann Oncol. 2017 Jul 1;28(7):1532-1539
pubmed: 28407039
Lancet Oncol. 2016 May;17(5):642-50
pubmed: 27080216
Oncotarget. 2015 Jun 10;6(16):14209-19
pubmed: 25895031
PLoS Med. 2008 Sep 30;5(9):e185
pubmed: 18788891
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
J Clin Oncol. 2018 Mar 1;36(7):633-641
pubmed: 29337640
J Thorac Oncol. 2018 Aug;13(8):1128-1137
pubmed: 29723688
Cancer Discov. 2015 Aug;5(8):842-9
pubmed: 25971939
Thorac Cancer. 2021 Jan;12(2):218-226
pubmed: 33210451
J Thorac Oncol. 2017 Feb;12(2):403-407
pubmed: 27765535
Cancer Discov. 2013 Dec;3(12):1330-2
pubmed: 24327693
Lancet Oncol. 2018 Dec;19(12):1654-1667
pubmed: 30413378
Ann Oncol. 2016 Feb;27(2):281-6
pubmed: 26598547
N Engl J Med. 2017 Jun 22;376(25):2415-2426
pubmed: 28636851
Lancet Oncol. 2017 Oct;18(10):1307-1316
pubmed: 28919011
Lancet. 2021 Feb 13;397(10274):592-604
pubmed: 33581821
Lancet. 2019 May 4;393(10183):1819-1830
pubmed: 30955977
Lancet Oncol. 2020 Feb;21(2):261-270
pubmed: 31838015
N Engl J Med. 2012 Jun 28;366(26):2517-9
pubmed: 22658126
Cancer Res Treat. 2018 Jan;50(1):95-102
pubmed: 28301925
Clin Cancer Res. 2019 Feb 1;25(3):1063-1069
pubmed: 30045933